NextDose.AI
NextDose.AI Inc. · Delaware Corporation · Back to Home

NextDose.AI — Terms of Service

Effective Date: April 13, 2026

Entity: NextDose.AI Inc., a corporation incorporated in the State of Delaware ("Company," "NextDose.AI," "we," "us," or "our")

Application: NextDose.AI mobile application ("App," "Service," or "Platform"). References to "NextDose," "NextDose.AI," "NextDose AI," or any variation thereof refer to the same entity, platform, and brand. Unless otherwise specified, all rights, protections, waivers, and obligations granted to or imposed on behalf of the Company under these Terms extend equally to its founders, owners, shareholders, parent company, subsidiaries, affiliates, investors, advisors, officers, directors, employees, contractors, agents, and assigns (collectively with the Company, the "Released Parties").

IMPORTANT NOTICE

These Terms of Service ("Terms") constitute a legally binding agreement between you ("User," "you," or "your") and NextDose.AI Inc. These Terms contain provisions of critical importance, including:

PLEASE READ THESE TERMS CAREFULLY BEFORE USING THE APP. BY USING THE APP, YOU AGREE TO BE BOUND BY THESE TERMS.

TABLE OF CONTENTS

1. Acceptance of Terms

2. Description of Service

3. Not Medical Advice — Critical Disclaimer

4. Assumption of Risk

5. Limitation of Liability

6. Waiver of Right to Lawsuit

7. Mandatory Binding Arbitration

8. Class Action Waiver and Jury Trial Waiver

9. Indemnification

10. User Accounts and Eligibility

11. Subscription and Payments

12. User Data and Privacy

13. NextDose Network and Third-Party Services

14. Community Features

15. Intellectual Property

16. Compound Information Disclaimer

17. AI Features Disclaimer

18. Reconstitution and Informational Tools

19. Prohibited Uses

20. Content Standards and Moderation

21. Termination

22. Governing Law and Forum Selection

23. Modifications

24. Severability

25. Entire Agreement

26. General Provisions

27. Enterprise and Business Accounts

28. Contact Information

1. ACCEPTANCE OF TERMS

1.1 Binding Agreement

By downloading, installing, accessing, or using the NextDose.AI application, you acknowledge that you have read, understood, and agree to be bound by these Terms, our Privacy Policy, and all applicable laws and regulations. If you do not agree to any provision of these Terms, you must immediately cease all use of the App and delete it from your device.

Your use of NextDose.AI constitutes a legally binding agreement. These Terms are effective as of the date you first access or use the App.

1.2 Acknowledgment of Voluntariness and Opportunity to Review

By accepting these Terms, you acknowledge and represent that: (a) these Terms were available to you for review prior to account creation and you had a meaningful opportunity to read, understand, and consider these Terms before accepting them; (b) your acceptance of these Terms was voluntary and not the product of coercion, duress, or undue influence; (c) the limitations, waivers, indemnification obligations, dispute resolution provisions, and liability caps contained herein are a material part of the bargain between the parties; and (d) NextDose.AI Inc. would not provide you with access to the App absent your agreement to these provisions. You further acknowledge that these Terms, including their dispute resolution, liability limitation, and waiver provisions, are reasonable and proportionate given the nature of the Service, the voluntary nature of your use, and the pricing of the App.

1.3 Unilateral Amendment Right

The Company reserves the right to modify, update, or revise these Terms at any time, in its sole and absolute discretion, without prior notice or consent. When we make changes, we will update the "Last Updated" date at the top of this document and, where practicable, provide notice through in-app notification, push notification, or email to the address associated with your account. Your continued use of the App after the updated "Last Updated" date constitutes your binding acceptance of the revised Terms. If you do not agree to the updated Terms, your sole and exclusive remedy is to discontinue use of the App and delete your account. No amendment, modification, or waiver of these Terms by you shall be effective unless set forth in a writing signed by an authorized officer of the Company.

2. DESCRIPTION OF SERVICE

NextDose.AI is a personal health journaling, fitness tracking, and wellness organization application designed for competitive physique athletes, bodybuilders, biohackers, and health-conscious individuals. The App provides users with tools to:

3. NOT MEDICAL ADVICE — CRITICAL DISCLAIMER

3.1 Informational Purposes Only

NEXTDOSE.AI IS NOT A MEDICAL DEVICE, MEDICAL SERVICE, OR HEALTHCARE PROVIDER. The App has not been evaluated, approved, cleared, or authorized by the U.S. Food and Drug Administration ("FDA") or any other regulatory authority as a medical device, diagnostic tool, or therapeutic intervention.

All content, features, AI-generated outputs, compound profiles, informational data, bloodwork visualizations, pharmacokinetic estimates, side effect information, protocol organization tools, and any other information provided through the App is strictly for personal journaling, informational, and educational purposes only.

3.2 No Healthcare Relationship

Use of NextDose.AI does not create a doctor-patient relationship, a provider-patient relationship, or any healthcare relationship of any kind between you and the Company, its operators, employees, contractors, affiliates, AI service providers, or any third party.

3.3 Not a Substitute for Professional Medical Advice

NextDose.AI is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition, medication, supplement, compound, or health concern. Never disregard professional medical advice or delay seeking it because of information obtained through NextDose.AI.

3.4 AI Output Disclaimer

All AI-generated content within NextDose.AI — including but not limited to informational summaries, compound descriptions, bloodwork visualizations, research summaries, protocol analysis, PCT planning outputs, and protocol organization suggestions — is generated by artificial intelligence systems and has not been reviewed, verified, or approved by a licensed healthcare professional. AI outputs may contain errors, inaccuracies, omissions, or incomplete information.

AI outputs are presented with confidence indicators and source attributions where feasible, but no AI output constitutes medical advice, diagnosis, or treatment recommendation. You are solely responsible for all decisions made based on AI-generated content and must consult a qualified healthcare professional before changing any diet, supplementation, training, or health practices.

3.5 For Research and Educational Use

All peptide-related and research compound content within NextDose.AI is presented under a "For Research Use Only" framework. References to peptides, research chemicals, and investigational compounds are provided for informational and educational purposes. The Company does not manufacture, sell, distribute, prescribe, or recommend the purchase of any compound, medication, supplement, or substance.

3.6 Regulatory Status Transparency

Each compound profile within NextDose.AI includes its current regulatory status as known to us, which may include designations such as:

Regulatory status information is provided for educational purposes and may not reflect the most current regulatory actions. Users are solely responsible for understanding and complying with all applicable federal, state, and local laws regarding any compounds they use, possess, or track.

3.7 Consult Your Healthcare Provider

You should consult with a qualified healthcare provider before starting, stopping, or modifying any supplement, medication, fitness program, or wellness protocol. This recommendation applies regardless of any information displayed within the App.

4. ASSUMPTION OF RISK

4.1 Voluntary Use

You acknowledge and agree that your use of NextDose.AI is entirely voluntary. You understand that the App is a personal journaling and informational tool, and that all decisions regarding supplement use, wellness protocols, fitness training, body composition modification, performance optimization, and related activities are made solely by you or in consultation with your qualified healthcare provider.

4.2 Inherent Risks of Fitness and Supplementation

You expressly acknowledge that fitness training, body composition modification, performance optimization, and the use of supplements, vitamins, prescription medications, and other compounds carry inherent risks of physical injury, illness, adverse health outcomes, or death. The nature and severity of such risks varies by individual, by substance, and by activity. These risks include but are not limited to: adverse reactions, side effects, drug interactions, allergic reactions, cardiovascular events, hormonal disruption, organ damage, and other health consequences.

4.3 Full Assumption of Risk

YOU VOLUNTARILY ASSUME ALL RISK ASSOCIATED WITH YOUR PERSONAL HEALTH AND WELLNESS DECISIONS, INCLUDING ANY DECISIONS RELATED TO COMPOUNDS, PROTOCOLS, TRAINING, OR ACTIVITIES TRACKED WITHIN THE APP. The Company makes no warranties regarding the safety, suitability, or efficacy of any training, dietary, or supplementation content in the App and shall have no liability for any physical injury, health deterioration, adverse reaction, or death arising from use of or reliance on the App.

5. LIMITATION OF LIABILITY

5.1 Waiver of Claims

To the maximum extent permitted by applicable law, you waive, release, and forever discharge the Company and all Released Parties from any and all claims, demands, causes of action, damages, losses, costs, expenses (including attorneys' fees and expert witness fees), liabilities, and obligations of every kind and nature, whether known or unknown, suspected or unsuspected, disclosed or undisclosed, past, present, or future, that arise from or relate to:

(a) Your use of, or inability to use, the App or any information obtained through the App;

(b) Any health, wellness, fitness, training, or medical decisions made by you, regardless of whether such decisions were informed by, influenced by, or made in connection with information displayed within the App;

(c) Any adverse health outcomes, side effects, allergic reactions, drug interactions, injuries, hospitalization, disability, or death, whether or not foreseeable;

(d) Any reliance on AI-generated content, compound profiles, dosing information, research summaries, bloodwork analysis, protocol analysis, PCT planning outputs, or any other informational material within the App;

(e) Any errors, inaccuracies, omissions, outdated information, or incomplete information in any App content, whether generated by AI, sourced from third parties, or curated by the Company;

(f) Any interaction, transaction, consultation, or relationship with clinics, healthcare providers, research labs, vendors, or any third parties discovered through or referenced in the App;

(g) Any unauthorized access to, alteration of, loss of, or destruction of your data, whether caused by security breach, system failure, or any other cause;

(h) Any interruption, suspension, modification, or cessation of the Service, whether temporary or permanent;

(i) Any changes to pricing, features, subscription terms, or availability of the App;

(j) Any actions taken or not taken based on push notifications, reminders, AI recommendations, or any automated communications from the App.

You acknowledge that you have been advised to consult with legal counsel regarding this waiver and that you fully understand its implications. You intend this waiver to be as broad and inclusive as permitted by the laws of the State of Delaware.

5.2 No Consequential Damages

IN NO EVENT SHALL THE COMPANY OR ANY RELEASED PARTY BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR MULTIPLIED DAMAGES OF ANY KIND, INCLUDING BUT NOT LIMITED TO DAMAGES FOR LOSS OF PROFITS, REVENUE, GOODWILL, USE, DATA, HEALTH, WELLBEING, BODILY INJURY, EMOTIONAL DISTRESS, OR OTHER TANGIBLE OR INTANGIBLE LOSSES, REGARDLESS OF WHETHER SUCH DAMAGES ARE BASED ON CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY, WARRANTY, STATUTE, OR ANY OTHER LEGAL THEORY, AND EVEN IF THE COMPANY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES OR COULD HAVE FORESEEN SUCH DAMAGES.

5.3 Liability Cap

To the extent permitted by applicable law, the total aggregate liability of the Company and all Released Parties, collectively, for all claims of any kind arising out of or relating to these Terms, the App, or your use of the Service shall not exceed the lesser of: (a) the total amount you actually paid to the Company in subscription fees during the six (6) months immediately preceding the event giving rise to the claim; or (b) one hundred U.S. dollars ($100.00). This cap applies regardless of the number of claims, the legal theory asserted, or the number of Released Parties involved.

For the avoidance of doubt, if you are a free-tier User who has never paid any subscription fees, the maximum aggregate liability of the Company to you for all claims of any kind shall not exceed ten U.S. dollars ($10.00).

5.4 Standing Requirement

You acknowledge and agree that you may not bring any claim against the Company unless you have suffered actual, concrete, and particularized harm directly and proximately caused by the Company, as required by Article III of the United States Constitution or applicable state standing requirements. Technical violations of these Terms or applicable law — whether under federal or state law — without real, demonstrable injury do not constitute valid claims. Speculative harm, de minimis harm, or harm that is not fairly traceable to the Company's conduct does not confer standing to bring a claim under either federal or state law.

5.5 Shortened Statute of Limitations

ALL CLAIMS ARISING OUT OF OR RELATING TO THESE TERMS, THE APP, OR YOUR USE OF THE SERVICE MUST BE FILED WITHIN ONE (1) YEAR OF THE DATE THE ACT OR OMISSION GIVING RISE TO THE CLAIM OCCURRED, REGARDLESS OF WHEN THE CLAIM WAS DISCOVERED OR COULD HAVE BEEN DISCOVERED. Any claim not filed within this one-year period is permanently and irrevocably barred. This shortened limitations period applies to the fullest extent permitted by applicable law and supersedes any longer statute of limitations that might otherwise apply.

5.6 Anti-Solicitation of Claims

You agree that you will not solicit, recruit, encourage, fund, or facilitate any other User of the App to bring a claim, demand, arbitration, lawsuit, or legal proceeding of any kind against the Company. You agree not to participate in, provide information for, or cooperate with any effort by any attorney, law firm, litigation funder, or third party to identify, recruit, or organize current or former Users for the purpose of initiating claims against the Company, except as compelled by valid legal process. Any User who solicits or facilitates claims by other Users in violation of this Section shall be liable for the Company's attorneys' fees and costs incurred in defending against such solicited claims. This provision does not restrict your right to file your own individual claim through the arbitration process set forth in Section 7.

5.7 Third-Party Litigation Funding Disclosure

If any claim or arbitration demand you file against the Company is funded, supported, or financed in whole or in part by any third party (including but not limited to litigation funders, law firms operating on contingency, or any entity with a financial interest in the outcome), you must disclose the identity of all such third parties and the terms of the funding arrangement to the Company and the arbitrator within fourteen (14) days of filing the claim. Failure to disclose constitutes a material breach of these Terms and grounds for dismissal of the claim.

5.8 Essential Basis of the Bargain

The limitations and exclusions set forth in this Section 5 shall apply even if any remedy provided under these Terms is found to have failed its essential purpose. You acknowledge that the Company has set its pricing and entered into these Terms in reliance upon the limitations of liability, disclaimers, and risk allocations set forth herein, and that these provisions form an essential basis of the bargain between the parties.

6. WAIVER OF RIGHT TO LAWSUIT

6.1 Waiver

To the maximum extent permitted by applicable law, you waive all rights to bring legal action — including but not limited to lawsuits, claims, demands, complaints, proceedings, investigations, regulatory actions, or actions of any kind — against the Company and all Released Parties for any outcomes, damages, injuries, losses, costs, or consequences related to your use of the App, your health or fitness decisions, or any information obtained through the App. This waiver extends to claims you may not yet be aware of or that may arise in the future.

6.2 Covenant Not to Sue

You covenant and agree that you will not institute, maintain, join, fund, support, encourage, or cause to be instituted or maintained any action, suit, proceeding, complaint, regulatory action, or investigation of any kind against any Released Party arising out of or related to your use of the App, your health or fitness decisions, or your reliance on any App content, except as provided in the Mandatory Arbitration section below. This covenant extends to actions brought by you individually, through an attorney, through a regulatory body on your behalf, or through any third party acting at your direction or on your behalf.

6.3 Acknowledgment of Voluntariness

You acknowledge and represent that: (a) your use of the App is entirely voluntary; (b) you have had the opportunity to consult with legal counsel before accepting these Terms; (c) you understand the legal significance of waiving your right to bring legal action; (d) you are not relying on any representations or statements by the Company other than those contained in these Terms; and (e) this waiver is given freely, knowingly, and voluntarily.

7. MANDATORY BINDING ARBITRATION

7.1 Informal Resolution First

Before initiating any arbitration or legal proceeding, you and the Company agree to first attempt to resolve any dispute informally. The party asserting the claim must send a written notice describing the nature of the claim, the specific relief sought, and the factual basis for the claim to the other party (by email to [email protected] for claims against the Company, or to your registered email address for claims against you). The parties shall have thirty (30) days from receipt of such notice to attempt to resolve the dispute informally. If the dispute is not resolved within thirty (30) days, either party may initiate arbitration as set forth below. No arbitration demand may be filed until this thirty-day informal resolution period has expired.

7.2 Agreement to Arbitrate

If the informal resolution process described in Section 7.1 does not resolve the dispute, you and the Company agree that any dispute, claim, or controversy arising out of or relating to these Terms, the App, or your use of the Service — including the determination of the scope or applicability of this agreement to arbitrate — shall be resolved exclusively through final and binding individual arbitration, rather than in court, except that you may assert individual claims in small claims court if your claims qualify and remain in small claims court.

7.3 Arbitration Rules and Forum

Arbitration shall be administered by the American Arbitration Association ("AAA") in accordance with its Consumer Arbitration Rules then in effect. The arbitration shall be conducted by a single neutral arbitrator selected in accordance with AAA rules. The arbitration shall take place in the State of Maryland at a location chosen by the Company, or at such other location as may be mutually agreed upon by the parties. The arbitrator's decision shall be final and binding and may be entered as a judgment in any court of competent jurisdiction. The arbitrator shall apply the substantive laws of the State of Delaware, without regard to conflict of law principles.

7.4 Individual Claims Only

All disputes must be brought and resolved on an individual basis only. The arbitrator may award relief only in favor of the individual party seeking relief and only to the extent necessary to provide relief warranted by that party's individual claim. The arbitrator shall have no authority to consolidate claims, certify a class, or preside over any form of consolidated, representative, or class proceeding.

7.5 Scope of Arbitration

The arbitrator shall have exclusive authority to resolve any dispute relating to the interpretation, applicability, enforceability, or formation of this arbitration agreement, including any claim that all or any part of this agreement is void or voidable. The arbitrator shall also have exclusive authority to determine the arbitrability of any dispute.

7.6 Arbitration Costs and Fee-Shifting

The Company shall pay all AAA filing fees and arbitrator fees for claims where the amount in controversy is under $10,000. For claims over $10,000, the AAA Consumer Arbitration Rules shall govern payment of filing fees and arbitrator fees. Each party shall bear its own attorneys' fees and costs, subject to the following:

(a) Fee-Shifting Upon Prevailing. If the Company prevails in any arbitration or litigation proceeding and the arbitrator or court finds that the claim was filed without substantial justification, frivolously, or in bad faith, such finding shall constitute grounds for an award of all of the Company's reasonable attorneys' fees, arbitration costs, and legal expenses against the claimant.

(b) Frivolous Claim Penalty. Any claim that the arbitrator determines to be frivolous, brought in bad faith, or without reasonable basis in law or fact shall constitute grounds for an award of the Company's reasonable attorneys' fees and costs. The arbitrator shall have full discretion to make such an award upon finding that the claim lacked substantial justification.

(c) AAA Fee Rule Qualifier. The fee-shifting provisions set forth in Sections 7.6(a) and 7.6(b) apply to the extent permitted by the applicable arbitration rules and administrator. In the event the applicable arbitration rules conflict with the fee-shifting provisions herein, the parties agree to apply the most protective fee arrangement available under those rules while preserving the intent of these provisions to the maximum extent enforceable.

7.7 Equitable Relief Carve-Out

Notwithstanding any provision of this arbitration agreement, the Company may seek injunctive relief, temporary restraining orders, preliminary injunctions, or other equitable relief in any court of competent jurisdiction immediately and without first completing the informal resolution process set forth in Section 7.1, and without waiving its right to compel arbitration on all other claims. The exercise of this right shall not constitute a waiver of the Company's right to submit any other dispute to arbitration.

7.8 Confidentiality of Arbitration

All aspects of the arbitration proceeding, including but not limited to the existence of the dispute, any filings, testimony, evidence, the arbitrator's decision, and the award, shall be kept strictly confidential by both parties. Neither party shall disclose any information about the arbitration to any third party, except as may be required by law, to enforce the arbitration award, or to seek judicial review of the award.

7.9 Opt-Out Right

You may opt out of this arbitration agreement by sending written notice to [email protected] within thirty (30) days of first accepting these Terms. The opt-out notice must include your full name, email address associated with your account, a clear statement that you wish to opt out of the arbitration agreement, and your physical mailing address. Opting out of arbitration does not affect any other provision of these Terms, including the liability waiver, class action waiver, jury trial waiver, and indemnification obligations. If you do not opt out within thirty (30) days, you are permanently bound by this arbitration agreement.

8. CLASS ACTION WAIVER AND JURY TRIAL WAIVER

8.1 Class Action Waiver

YOU AND THE COMPANY AGREE THAT EACH PARTY MAY BRING CLAIMS AGAINST THE OTHER ONLY IN YOUR OR ITS INDIVIDUAL CAPACITY, AND NOT AS A PLAINTIFF, CLASS MEMBER, OR PARTICIPANT IN ANY PURPORTED CLASS, COLLECTIVE, CONSOLIDATED, MULTI-DISTRICT, OR REPRESENTATIVE PROCEEDING, INCLUDING BUT NOT LIMITED TO CLASS ACTIONS, PRIVATE ATTORNEY GENERAL ACTIONS (PAGA OR EQUIVALENT), OR MASS ARBITRATIONS. Unless both you and the Company agree otherwise in writing, the arbitrator may not consolidate or join more than one person's or party's claims, may not preside over any form of a consolidated, representative, or class proceeding, and may not award relief to anyone other than the individual party seeking relief.

8.2 No Mass Arbitration

You agree not to participate in any coordinated or mass arbitration filing against the Company. If twenty-five (25) or more similar arbitration demands are filed against the Company within a ninety-day period, the parties agree to engage in a bellwether process: ten (10) cases shall be randomly selected and arbitrated individually, and the outcomes shall inform resolution of the remaining cases through mediation before additional arbitrations proceed.

8.3 Jury Trial Waiver

TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, YOU AND THE COMPANY EACH IRREVOCABLY AND UNCONDITIONALLY WAIVE ANY RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THESE TERMS, THE APP, OR YOUR USE OF THE SERVICE. This waiver applies to any proceeding in any forum, whether in arbitration, in court, or otherwise.

8.4 Severability of Class Action Waiver

If the class action waiver set forth in Section 8.1 is found to be unenforceable by a court of competent jurisdiction, then the entirety of the arbitration agreement (Section 7) shall be null and void, and any dispute shall proceed exclusively in the state or federal courts located in the State of Delaware under the governing law provisions of Section 22. This severability provision ensures that an unenforceable class action waiver does not result in class-wide arbitration, which would be contrary to the intent of the parties.

9. INDEMNIFICATION

9.1 Indemnification Obligation

You agree to defend, indemnify, and hold harmless the Company and all Released Parties from and against any and all claims, actions, proceedings, investigations, demands, suits, judgments, settlements, costs, expenses, losses, liabilities, and damages of any kind (including reasonable attorneys' fees, expert witness fees, court costs, arbitration costs, costs of investigation, fines, penalties, and settlements) arising out of or relating to:

(a) Your use of, access to, or inability to access the App or Service;

(b) Your violation of these Terms, in whole or in part;

(c) Your violation of any applicable federal, state, local, or international law, rule, regulation, or ordinance;

(d) Any third-party claim arising from your conduct, including claims by family members, dependents, employers, insurers, healthcare providers, or governmental entities;

(e) Your health, wellness, fitness, training, or medical decisions or activities, regardless of whether such decisions were informed by App content;

(f) Any dispute, transaction, or interaction between you and a clinic, healthcare provider, research lab, vendor, or any third party discovered through, referenced in, or accessed via the App;

(g) Any claim that your User Content infringes or violates any third party's intellectual property, privacy, publicity, or other rights;

(h) Your breach of any representation or warranty made in these Terms;

(i) Any regulatory investigation, governmental inquiry, or law enforcement action arising from your use of the App or your activities.

Notwithstanding the foregoing, your indemnification obligation under this Section 9 shall not apply to the extent that a claim arises directly and solely from the Company's own gross negligence or willful misconduct.

9.2 Survival

This indemnification obligation survives the termination of your account and these Terms indefinitely. The Company reserves the right to assume exclusive control of the defense of any matter subject to indemnification by you, at your expense. You agree not to settle any such matter without the prior written consent of the Company. You agree to cooperate fully with the Company in the defense of any such claim.

10. USER ACCOUNTS AND ELIGIBILITY

10.1 Age Requirement

You must be at least eighteen (18) years of age to create an account and use NextDose.AI. By creating an account, you represent and warrant that you are at least 18 years old. We verify age during the account creation process and may request additional age verification at any time.

10.2 Account Accuracy

You agree to provide accurate, current, and complete information during the registration process and to update such information to keep it accurate, current, and complete.

10.3 Account Security

You are responsible for safeguarding your account credentials and for all activities that occur under your account. You agree to notify the Company immediately of any unauthorized use of your account at [email protected].

10.4 Medical Supervision Acknowledgment

By creating an account, you represent that you are either: (a) managing your personal health, fitness, and wellness routines under the guidance of a licensed healthcare provider; or (b) using the App solely for educational, informational, personal journaling, or legitimate research purposes.

10.5 Single User Accounts

Each account is for a single individual. You may not share your account credentials or allow others to access your account. Health data within your account should pertain solely to you.

11. SUBSCRIPTION AND PAYMENTS

11.1 Subscription Plans

NextDose.AI offers multiple subscription tiers (including Free and Pro) at various price points and billing intervals (monthly, annual, or as otherwise offered), which may include promotional pricing, holiday pricing, personalized offers, or free trial periods. All prices are displayed at the point of purchase within the App and may vary by user, region, promotional period, or other factors at the Company's sole discretion. Pricing is subject to change at any time without prior notice. The price displayed to you at the time of your purchase or renewal is the price that applies to that transaction. Feature availability may vary by subscription tier and is subject to change at the Company's sole discretion.

11.2 Free Trial

New users may be eligible for a free trial period as displayed at the point of purchase. The trial automatically converts to a paid subscription at the end of the trial period unless cancelled at least twenty-four (24) hours before the trial expires. Cancellation during the trial period incurs no charges. Trial duration, eligibility, and availability are subject to change at the Company's sole discretion.

11.3 Billing and Renewal

11.4 Cancellation

You may cancel your subscription at any time through your Apple ID account settings (App Store > Apple ID > Subscriptions). Cancellation takes effect at the end of the current billing period. You will retain access to premium features until the end of your paid period.

11.5 Price Changes

The Company reserves the right to change subscription pricing at any time. Price changes for existing subscribers will be communicated at least thirty (30) days in advance and will take effect at the next renewal date. You may cancel before the price change takes effect.

11.6 Restore Purchases

You may restore previously purchased subscriptions on any device signed into your Apple ID through the App's settings.

11.7 Safety Information Access

Critical safety information including compound interaction warnings, contraindication alerts, and emergency safety notices are available to all users regardless of subscription status. Safety-critical information is never gated behind the subscription paywall.

12. USER DATA AND PRIVACY

12.1 Privacy Policy

Your use of NextDose.AI is also governed by our Privacy Policy, which is incorporated into these Terms by reference. Please review the Privacy Policy carefully for a complete description of how we collect, use, retain, and protect your data.

12.2 Data Ownership

You retain ownership of your personal data, health protocol logs, bloodwork results, progress photos, and other User Content you submit to the App. You grant the Company a non-exclusive, worldwide, royalty-free, sublicensable, transferable license to use, process, store, transmit, and display your User Content solely for the purpose of providing, maintaining, and improving the Service and as otherwise described in our Privacy Policy.

12.3 De-Identified Data

You acknowledge and consent to the Company creating de-identified and aggregate datasets from User Content in accordance with the de-identification practices described in our Privacy Policy. De-identified data cannot be used to identify you personally and is not considered your Personal Information.

12.4 Account Deletion

You may delete your account and request deletion of your associated data at any time through the in-app account deletion feature (Settings > Account > Delete Account) or by contacting [email protected]. Certain legal protection records are retained after deletion as described in Section 8.3 of our Privacy Policy.

13. NEXTDOSE NETWORK AND THIRD-PARTY SERVICES

13.1 Healthcare Provider Directory

The NextDose Network is an informational directory within the App consisting of three categories:

(a) Telehealth Clinics. A directory of licensed telehealth and virtual healthcare providers offering consultations for hormone health, wellness optimization, and related medical services.

(b) Hormone Health Clinics. A location-based directory of licensed brick-and-mortar clinics specializing in hormone therapy, men's health, women's health, and related medical services.

(c) Research Labs. An informational directory of research compound suppliers and analytical laboratories. All research lab listings are presented under a "For Research Use Only" framework.

13.2 No Endorsement

The inclusion of any clinic, healthcare provider, telehealth platform, or research lab in the NextDose Network does not constitute an endorsement, recommendation, or guarantee by the Company regarding the quality, safety, legality, or suitability of their services or products.

13.3 No Agency

The listing of any provider or lab in the NextDose Network does not create any agency, partnership, joint venture, or employment relationship between the Company and that entity.

13.4 Independent Verification

You are solely responsible for independently verifying the credentials, licensing, qualifications, and suitability of any healthcare provider or research lab before engaging their services. The Company does not verify, credential, or monitor the providers and labs listed in the NextDose Network.

13.5 Transactions and Relationships

Any interactions, communications, appointments, or financial transactions between you and a provider or lab discovered through the App are solely between you and that third party. The Company is not a party to any such transaction and has no liability arising from it.

13.6 Location Services

The Hormone Health Clinics directory uses your device location (with your explicit permission) to display nearby clinics and personalize your experience. Location data is used in accordance with our Privacy Policy. The App functions without location permission; location-based search will be unavailable.

13.7 Research Use Disclaimer

All research lab listings and research compound information within the NextDose Network are provided for informational and educational purposes only under a "For Research Use Only" framework. The Company does not manufacture, sell, distribute, or facilitate the sale of any compound, substance, or product. Users are solely responsible for ensuring their activities comply with all applicable laws.

14. COMMUNITY FEATURES

14.1 Community Content

The App may include community features that display publicly available discussion content aggregated from third-party platforms for informational and educational purposes.

14.2 Content Moderation

In compliance with Apple App Store Review Guideline 1.2, all community features include:

14.3 No Endorsement of Community Content

The Company does not endorse, verify, or guarantee the accuracy of community content. Community content reflects the views and experiences of third parties, not of the Company. Always verify health-related community content with a qualified healthcare provider.

14.4 User Responsibility

If future versions of the App enable user-submitted community content, you agree not to post content that is false, misleading, defamatory, threatening, harassing, obscene, or that violates any applicable law. You agree not to share personal health information of others or post content that could be interpreted as medical advice.

15. INTELLECTUAL PROPERTY

15.1 App Ownership

NextDose.AI, including but not limited to its design, user interface, user experience, source code, algorithms, AI models, AI prompts, pharmacokinetic estimation engines, compound database compilation, data organization methodology, informational content, trademarks, logos, trade dress, brand identity, and all related intellectual property, is the exclusive property of NextDose.AI Inc. and its licensors. These Terms do not grant you any right, title, or interest in the App except for the limited, non-exclusive, non-transferable, revocable license to use it strictly in accordance with these Terms.

15.2 Trade Secrets

The following are designated as trade secrets and proprietary information of the Company: (a) the compilation, organization, structure, and presentation of compound data within the App; (b) all AI prompt engineering, model configurations, and AI processing pipelines; (c) pharmacokinetic estimation algorithms and blood level calculation methodologies; (d) the App's data architecture, database schema, and API design; (e) user engagement patterns, analytics methodologies, and business intelligence derived from App usage; (f) all internal documentation, design specifications, and development processes. Unauthorized disclosure, reproduction, or use of any trade secret constitutes a material breach of these Terms.

15.3 Confidentiality and Non-Misappropriation

You acknowledge that through your use of the App, you may be exposed to proprietary information, trade secrets, and confidential business information of the Company, including but not limited to: the App's data architecture, AI prompt engineering, pharmacokinetic algorithms, compound database compilation methodology, user experience design patterns, and business processes (collectively, "Confidential Information"). You agree that you shall NOT, directly or indirectly, whether individually, through a business entity, or in collaboration with any third party:

(a) Use any Confidential Information obtained through the App to develop, design, launch, or contribute to any product, service, application, or platform that competes with NextDose.AI;

(b) Disclose, publish, transmit, or make available any Confidential Information to any person or entity not authorized by the Company to receive it;

(c) Replicate, imitate, or create a derivative work of the App's proprietary data compilation, AI-generated analysis methodology, or trade secret algorithms using information obtained through your use of the App;

(d) Hire, solicit, recruit, or engage any current or former employee, contractor, developer, or contributor of the Company for the purpose of building a product that uses or is based upon the Company's Confidential Information;

(e) Use any portion of the App's proprietary content, data compilation, or AI-generated analysis as a foundation, reference, or template for any competing product or service.

For the avoidance of doubt, this Section 15.3 does not restrict your right to work in the health, fitness, or technology industries generally, nor does it restrict your use of publicly available scientific literature, government databases, or general industry knowledge that is not proprietary to the Company. This provision restricts only the misappropriation of the Company's specific Confidential Information and trade secrets. This obligation survives termination of your account and these Terms indefinitely.

Any violation of this section may subject you to liability under the federal Defend Trade Secrets Act (18 U.S.C. § 1836), the Delaware Uniform Trade Secrets Act (6 Del. C. § 2001 et seq.), the Computer Fraud and Abuse Act (18 U.S.C. § 1030), and any other applicable federal or state law protecting trade secrets and proprietary information, in addition to the remedies set forth in these Terms.

15.4 Data Scraping and Extraction Prohibition

You shall not, under any circumstances:

(a) Scrape, crawl, harvest, mine, extract, or collect any data, content, compound information, research data, AI-generated content, user-contributed content, or any other information from the App using any automated means;

(b) Manually compile, aggregate, or systematically copy data from the App for the purpose of creating a competing database, product, service, or publication;

(c) Access or attempt to access any data not intended for your use, including other users' data, internal analytics, or system configurations;

(d) Export, download, or transfer any data from the App beyond what is expressly provided through official export features intended for personal use.

15.5 Non-Solicitation of Users

You agree that you shall not, directly or indirectly, whether during your use of the App or after termination:

(a) Use the App, its community features, user directories, or any data obtained through the App to identify, contact, solicit, recruit, or market to other Users of NextDose.AI for the purpose of directing them to a competing product, service, or platform;

(b) Advertise, promote, or distribute information about a competing product or service within the App, its community features, or to Users identified through the App;

(c) Systematically contact, message, or reach out to Users of NextDose.AI through any channel (including social media, email, direct message, or in-person) for the purpose of migrating them to a competing product or service;

(d) Use aggregated, de-identified, or anonymized data from the App to target marketing campaigns toward NextDose.AI's user demographic for a competing product.

Any violation of this Section constitutes misappropriation of the Company's goodwill and customer relationships, and shall entitle the Company to injunctive relief under Section 15.7 and damages under Section 15.8.

15.6 Compound Data Sources

Compound informational data within the App is derived from published scientific literature, publicly available research databases, government resources (FDA, NIH, PubMed), and community-contributed data. While factual information regarding compound pharmacology may be publicly available, the Company's proprietary interest lies in the unique compilation, organization, curation, presentation, cross-referencing, AI-enhanced analysis, evidence scoring, and user experience design of such data. This compilation constitutes a protectable work under copyright and trade secret law.

15.7 Injunctive Relief

You acknowledge and agree that any breach or threatened breach of Sections 15.1 through 15.5 would cause irreparable harm to the Company for which monetary damages alone would be an inadequate remedy. Accordingly, the Company shall be entitled to seek immediate injunctive relief (including temporary restraining orders, preliminary injunctions, and permanent injunctions) in any court of competent jurisdiction, without the requirement of posting a bond or proving actual damages, in addition to any other remedies available at law or in equity.

15.8 Damages and Fee Recovery

In the event of a proven violation of Section 15.3 (Confidentiality and Non-Misappropriation) or Section 15.4 (Data Scraping), you agree to pay the greater of: (a) the Company's actual damages resulting from the violation; or (b) five thousand U.S. dollars ($5,000.00) per incident. The parties agree that actual damages from misappropriation of trade secrets and proprietary data are inherently difficult to calculate, and that this minimum per-incident amount represents a reasonable forecast of just compensation under the standard set forth in Brazen v. Bell Atlantic Corp., 695 A.2d 43 (Del. 1997). In addition, you shall be liable for all of the Company's reasonable attorneys' fees, expert witness fees, court costs, investigation costs, and other expenses incurred in enforcing this Section 15. This provision does not limit the Company's right to seek injunctive relief under Section 15.6 or statutory damages under the Defend Trade Secrets Act, the Delaware Uniform Trade Secrets Act, or the Computer Fraud and Abuse Act.

15.9 Feedback

Any feedback, suggestions, feature requests, or ideas you provide regarding the App become the exclusive property of the Company without any obligation of compensation, attribution, or confidentiality to you.

15.10 Personal Obligations

Your obligations under this Section 15 are personal to you as the individual who accepted these Terms. If you access or use the App on behalf of, for the benefit of, or at the direction of any business entity, you represent and warrant that you have authority to bind that entity to these Terms, and both you individually and the entity shall be jointly and severally liable for any violation of this Section 15. For business and enterprise accounts, additional personal guaranty provisions apply as set forth in Section 27.

15.11 Survival

All provisions of this Section 15 shall survive the termination or expiration of these Terms and your account indefinitely, including but not limited to the confidentiality and non-misappropriation obligations (Section 15.3), data scraping prohibitions (Section 15.4), non-solicitation of users (Section 15.5), injunctive relief rights (Section 15.7), damages and fee recovery provisions (Section 15.8), and personal obligations (Section 15.10).

16. COMPOUND INFORMATION DISCLAIMER

16.1 Informational Only

All compound profiles, pharmacological data, dosing ranges, half-life estimates, pharmacokinetic estimates, side effect profiles, and interaction data within NextDose.AI are provided for informational and educational purposes only. This information is derived from published research, government databases, and community data, and may not reflect the most current scientific understanding.

16.2 Not Prescribing Information

Compound information within the App is not prescribing information, labeling information, or clinical guidance. It should not be used as a basis for health decisions without consulting a qualified healthcare provider.

16.3 Accuracy Limitations

While we strive to maintain accurate compound data, we do not guarantee the completeness, accuracy, or currency of any compound information. Compound data may contain errors, may be outdated, or may not reflect individual variability in response. You should always verify compound information with authoritative sources and your healthcare provider.

16.4 Legal Compliance

Users are solely responsible for ensuring their activities comply with all applicable federal, state, and local laws. The inclusion of any compound in the NextDose.AI library does not constitute encouragement, facilitation, or endorsement of the use, possession, or distribution of that compound.

17. AI FEATURES DISCLAIMER

17.1 AI Limitations

AI features within NextDose.AI are powered by proprietary models and algorithms and are subject to inherent limitations including but not limited to: hallucination (generating plausible but incorrect information), outdated training data, inability to account for individual medical history, and inability to perform physical examination or diagnostic testing.

17.2 Not Medical Advice

No AI-generated content within NextDose.AI constitutes medical advice, diagnosis, or treatment recommendation. All AI-generated recommendations have not been reviewed by a licensed healthcare professional. Every AI output is accompanied by a disclaimer to this effect. AI outputs are informational starting points, not clinical conclusions. You are solely responsible for all decisions made based on App output and must consult a qualified healthcare professional before changing diet, supplementation, training, or health practices.

17.3 AI Output Reliance Warning

AI-generated outputs are probabilistic in nature, may be incomplete or inaccurate, and shall not be relied upon as the sole basis for any decision affecting health, safety, or wellbeing. You agree to independently verify any AI-generated recommendation, insight, analysis, or suggestion with a qualified healthcare professional before acting thereon. No single output from the App — whether generated by AI, derived from community data, or sourced from published literature — constitutes a sufficient basis for action regarding your health, fitness, training, supplementation, or medical care. You should always verify AI-generated information with authoritative sources and consult your healthcare provider before acting on any AI output.

17.4 Confidence Scores

Where feasible, AI outputs include confidence scores indicating the AI's estimated certainty. A high confidence score does not indicate medical validity — it indicates only the AI system's internal consistency assessment.

18. RECONSTITUTION AND INFORMATIONAL TOOLS

18.1 Informational Calculator

The reconstitution tool within NextDose.AI is a general-purpose informational calculator that performs standard dilution mathematics. It is provided for informational and educational purposes only.

18.2 Not a Drug Dosage Calculator

The reconstitution tool does not calculate, recommend, or suggest drug dosages. It performs mathematical calculations based on values you input and returns mathematical results. The tool does not know, infer, or recommend what dose is appropriate for any individual.

18.3 Verification Required

All calculations should be verified independently and discussed with your healthcare provider before use. Mathematical outputs are dependent on the accuracy of user-provided inputs.

18.4 Disclaimer Display

The reconstitution tool displays a prominent disclaimer before use, which you must acknowledge before accessing the calculator.

19. PROHIBITED USES

You agree not to:

(a) Use the App for any unlawful purpose or in violation of any applicable law or regulation;

(b) Attempt to reverse engineer, decompile, disassemble, or derive the source code, algorithms, AI prompts, data structures, or any proprietary technology of the App;

(c) Scrape, harvest, mine, extract, or collect any data from the App using automated or manual systematic means;

(d) Share your account credentials with others or allow unauthorized access to your account;

(e) Submit false, misleading, or fraudulent information;

(f) Use the App to distribute medical advice, diagnosis, or treatment recommendations to others;

(g) Use the App to encourage, facilitate, or promote illegal activity;

(h) Interfere with or disrupt the App's infrastructure, servers, or networks;

(i) Attempt to access other users' data or accounts;

(j) Use the App to harass, abuse, threaten, or intimidate any person;

(k) Upload malicious software, viruses, or other harmful code;

(l) Violate any applicable law, regulation, or third-party rights;

(m) Create, develop, fund, or contribute to any competing product that replicates or is substantially similar to NextDose.AI or any of its features (see Section 15.3);

(n) Use knowledge, insights, or methodologies gained through your use of the App to build, advise on, or improve any competing product or service;

(o) Recruit, solicit, or hire any current or former team member of the Company for the purpose of building a competing product;

(p) Circumvent, disable, or interfere with any security, access control, or usage tracking features of the App.

20. CONTENT STANDARDS AND MODERATION

20.1 Reporting

If you encounter content within the App that you believe is objectionable, harmful, inaccurate, or in violation of these Terms, please report it through the in-app reporting mechanism or by contacting [email protected].

20.2 Response

We will review reported content in a timely manner and take appropriate action, which may include content removal, user warning, or account suspension.

20.3 Contact

For content concerns, moderation inquiries, or to report a safety issue:

Email: [email protected]

21. TERMINATION

21.1 By You

You may terminate your account at any time by using the in-app account deletion feature (Settings > Account > Delete Account) or by contacting [email protected]. Please cancel your subscription through Apple before or concurrently with account deletion.

21.2 By the Company

The Company may suspend, restrict, or terminate any account at any time, for any reason or no reason, with or without notice, and without liability. Reasons for termination may include but are not limited to: violation of these Terms, fraudulent activity, abusive behavior, illegal activity, inactivity, or any other reason at the Company's sole discretion. Upon termination, your access to the App and all associated features ceases immediately. In the event the Company terminates a User with an active paid subscription, any refund obligations for App Store purchases are governed exclusively by Apple's then-current refund policies. The Company makes no independent refund commitments for purchases processed through Apple's platform.

21.3 Effects of Termination

Upon termination, your right to use the App ceases immediately. The following provisions shall survive any termination or expiration of these Terms: Sections 3 through 9 (Disclaimers, Assumption of Risk, Limitation of Liability, Waiver of Lawsuit, Arbitration, Class Action Waiver, and Indemnification), Section 12 (User Data and Privacy), Section 15 (Intellectual Property), Section 22 (Governing Law), and any other provision that by its nature should survive termination.

22. GOVERNING LAW AND FORUM SELECTION

22.1 Governing Law

These Terms shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to its conflict of law provisions. Delaware law governs all aspects of any dispute arising under or related to these Terms, including all arbitration proceedings, regardless of the venue in which arbitration is conducted and regardless of any contrary rules, default provisions, or choice-of-law provisions of the applicable arbitration administrator. Delaware law applies regardless of conflict of law principles of any jurisdiction.

22.2 Forum Selection — Arbitration

The agreed venue for arbitration proceedings shall be the State of Maryland at a location chosen by the Company, as set forth in Section 7.3.

22.3 Forum Selection — Litigation Fallback

If arbitration is deemed unenforceable or inapplicable for any reason — including but not limited to the voiding of the arbitration agreement pursuant to Section 8.4 — venue for all litigation shall be exclusively in the state and federal courts located in the State of Delaware. You irrevocably consent to the personal jurisdiction and venue of such courts and waive any objection to jurisdiction or venue, including on the basis of forum non conveniens.

23. MODIFICATIONS

The Company reserves the right to modify these Terms at any time, in its sole discretion. Notice of material changes will be provided by updating the "Last Updated" date and, where practicable, by in-app notification or email. Your continued use of the App after the updated date constitutes your binding acceptance of the modified Terms. If you do not agree to the modified Terms, your sole remedy is to discontinue use of the App and delete your account.

24. SEVERABILITY

If any provision of these Terms is found to be unenforceable or invalid by a court of competent jurisdiction or an arbitrator, that provision shall be limited or eliminated to the minimum extent necessary so that these Terms shall otherwise remain in full force and effect and enforceable. Notwithstanding the foregoing, if the Class Action Waiver set forth in Section 8.1 is specifically found to be unenforceable, the savings clause in Section 8.4 shall control and the entire arbitration agreement shall be voided as set forth therein.

25. ENTIRE AGREEMENT

These Terms, together with the Privacy Policy and any applicable subscription terms presented at the point of purchase, constitute the entire agreement between you and the Company regarding the use of the App and supersede all prior and contemporaneous agreements, communications, representations, warranties, and understandings, whether oral or written, including but not limited to any representations made in marketing materials, App Store listings, promotional communications, social media posts, or any other medium. No extrinsic evidence, whether oral or written, may be used to vary, contradict, or supplement the terms of this agreement.

26. GENERAL PROVISIONS

26.1 No Waiver

The failure of the Company to enforce any provision of these Terms shall not constitute a waiver of that provision or the right to enforce it at a later time. No waiver of any provision shall be effective unless set forth in a writing signed by an authorized officer of the Company.

26.2 Assignment

The Company may assign or transfer these Terms, in whole or in part, without restriction and without notice to you. You may not assign or transfer these Terms or any rights or obligations hereunder without the prior written consent of the Company.

26.3 Force Majeure

The Company shall not be liable for any failure or delay in performing its obligations where such failure or delay results from circumstances beyond its reasonable control, including but not limited to: natural disasters, war, terrorism, pandemics, government actions, labor disputes, internet or telecommunications failures, or third-party service provider outages.

26.4 Notices

Notices to the Company must be sent by email to [email protected]. Notices to you may be provided through the App, by email to the address associated with your account, or by any other reasonable means.

26.5 Headings

Section headings are for convenience only and shall not affect the interpretation of these Terms.

26.6 Construction

These Terms shall not be construed against the Company merely because the Company drafted them. Both parties acknowledge they have had the opportunity to review these Terms and seek legal counsel.

27. ENTERPRISE AND BUSINESS ACCOUNTS

28.1 Applicability

This Section 28 applies to any User who accesses or uses the App on behalf of a business entity, employer, organization, clinic, research institution, or any entity other than themselves as an individual consumer ("Business User"). If you create an account using a corporate email domain, register on behalf of an organization, or use the App in connection with your professional duties, you are a Business User and this Section applies to you in addition to all other provisions of these Terms.

28.2 Authority to Bind

By creating a Business Account or using the App on behalf of any entity, you represent and warrant that: (a) you have the legal authority to bind that entity to these Terms; (b) you have the authority to accept these Terms on behalf of that entity; and (c) the entity agrees to be bound by these Terms. If you do not have such authority, you accept these Terms in your individual capacity and assume personal responsibility for all obligations herein.

28.3 Personal Guaranty

If you are a Business User, you personally and unconditionally guarantee the performance of all obligations under these Terms by the entity on whose behalf you are acting. This guaranty is independent of the entity's obligations and shall not be released, discharged, or affected by any dissolution, bankruptcy, reorganization, or cessation of operations of the entity. This personal guaranty specifically covers obligations under Section 9 (Indemnification), Section 15 (Intellectual Property), and all payment obligations. You acknowledge that the Company is relying on this personal guaranty in providing access to the App and that this guaranty is a material part of the consideration for the Company's performance.

28.4 Enhanced Confidentiality Obligations

Business Users are subject to heightened confidentiality obligations. In addition to the obligations set forth in Section 15.3, Business Users agree that: (a) any Confidential Information obtained through the App shall not be shared with any employee, contractor, or agent of the Business User's entity except on a strict need-to-know basis; (b) the Business User shall implement reasonable administrative and technical safeguards to prevent unauthorized disclosure of Confidential Information; and (c) the Business User shall promptly notify the Company at [email protected] of any actual or suspected unauthorized disclosure of Confidential Information.

28.5 Non-Competition for Business Users

Business Users agree that during the term of their account and for a period of two (2) years following termination, they shall not, directly or indirectly, use Confidential Information obtained through the App to create, develop, fund, advise on, or contribute to any product, service, or platform that competes with NextDose.AI. This restriction applies to the Business User individually and to the entity on whose behalf they are acting. The parties acknowledge that this restriction is reasonable in scope and duration given the Business User's access to Confidential Information and that the Company would not provide access to the App absent this restriction. This provision is enforceable under the Delaware Uniform Trade Secrets Act and the federal Defend Trade Secrets Act.

28.6 Enhanced Damages for Business Users

In the event of a proven violation of Section 15.3, Section 15.4, or Section 28.5 by a Business User, the Business User and the entity on whose behalf they are acting agree to pay the greater of: (a) the Company's actual damages; or (b) fifty thousand U.S. dollars ($50,000.00) per incident, plus all reasonable attorneys' fees and costs. The parties agree that this enhanced minimum reflects the greater harm caused by institutional misappropriation of Confidential Information as compared to individual consumer violations, and constitutes a reasonable forecast of just compensation.

28.7 Non-Solicitation of Users — Enhanced for Business Users

In addition to the obligations set forth in Section 15.5, Business Users agree that: (a) they will not use any information obtained through the App, including user demographics, engagement patterns, community data, or market intelligence, to target, recruit, or solicit NextDose.AI users for any competing product or service; (b) they will not create marketing campaigns, advertising, or outreach that specifically targets individuals identifiable as NextDose.AI users; (c) if the Business User launches or contributes to a competing product within two (2) years of account termination, they will not use any information about NextDose.AI's user base, user preferences, or user behavior obtained through the App to inform the marketing, positioning, or feature development of such competing product. Violation of this Section constitutes misappropriation of the Company's goodwill, trade secrets, and customer relationships, and shall entitle the Company to injunctive relief, enhanced damages under Section 28.6, and all reasonable attorneys' fees and costs.

28.8 Audit Rights

The Company reserves the right to audit any Business User's compliance with these Terms, including Sections 15 and 28, upon thirty (30) days' written notice. The Business User agrees to cooperate with any such audit and to provide reasonable access to records and systems relevant to compliance verification. Failure to cooperate with an audit constitutes a material breach of these Terms.

28.9 Data Processing for Business Users

If a Business User's use of the App involves the processing of personal data of third parties (e.g., client data entered by a healthcare provider), the Business User represents and warrants that: (a) they have obtained all necessary consents and authorizations for such processing; (b) their use of the App complies with all applicable privacy and data protection laws; and (c) they will indemnify the Company against any claims arising from their processing of third-party personal data through the App.

28.10 Subscription Termination — Business Accounts

In the event the Company terminates a Business Account, any refund obligations for App Store purchases are governed exclusively by Apple's then-current refund policies. For enterprise subscriptions billed outside the App Store (if applicable), refunds shall be prorated based on the remaining term of the subscription, less any damages owed to the Company.

28.11 Insurance Recommendation

Business Users are strongly recommended to maintain professional liability insurance and cyber liability insurance with coverage limits adequate to cover their obligations under these Terms, including indemnification obligations. The Company may require proof of insurance as a condition of continued access for enterprise-tier accounts.

28. CONTACT INFORMATION

For questions about these Terms of Service, please contact:

NextDose.AI Inc.

A Delaware Corporation

Email: [email protected]

General Support: [email protected]

Privacy Inquiries: [email protected]

Website: nextdose.ai

BY CHECKING "I ACCEPT THE TERMS OF SERVICE" AND CREATING AN ACCOUNT, YOU ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD, AND AGREE TO BE BOUND BY THESE TERMS IN THEIR ENTIRETY, INCLUDING THE MANDATORY BINDING INDIVIDUAL ARBITRATION CLAUSE, CLASS ACTION WAIVER, JURY TRIAL WAIVER, COMPREHENSIVE LIABILITY WAIVER AND LIMITATION, ASSUMPTION OF RISK, SHORTENED STATUTE OF LIMITATIONS, FEE-SHIFTING PROVISIONS, INDEMNIFICATION OBLIGATION, AND ALL OTHER PROVISIONS SET FORTH HEREIN.

© 2026 NextDose.AI Inc. All rights reserved. Not a medical device.